AI may help decide who benefits from Clot-Busting procedure
NCT ID NCT07181083
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether an AI model can predict if a clot-removal procedure will work for people with severe deep vein thrombosis (DVT) in the leg. Thirty adults will receive a catheter-based treatment that breaks up and removes clots, and the AI will analyze MRI scans to see if it can forecast recovery. The goal is to help doctors avoid giving this invasive treatment to patients who are unlikely to benefit, reducing risks like kidney damage and bleeding.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
rtPA (a clot-dissolving drug) delivered via the AngioJet ZelanteDVT catheter
What this could lead to
If successful, this AI model could help doctors choose which patients with deep vein thrombosis will benefit most from clot-removal procedures, avoiding unnecessary risks.
What could go wrong
This is a small, early study with only 30 participants, so the AI model may not work well for all patients. The procedure itself carries risks like kidney injury and bleeding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEEP VEIN THROMBOSIS OF THE LOWER EXTREMITIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rajaie Cardiovascular Medical and Research Institute
Tehran, Tehran Province, 1995614331, Iran